There is one session available:
There is one session available:
Impacting the Opioid Crisis: Prevention, Education, and Practice for Non-Prescribing Providers
About this courseSkip About this course
This course will empower non-prescribing providers to directly impact the ongoing opioid crisis in the United States through increased knowledge and tools that will transform practice and policies. The course will inform you about the opioid epidemic and provide information and research about evidence-based strategies that are focused on prevention, intervention, education, or policy.
This open learning course is designed primarily for non-prescribing healthcare, behavioral health, dental and social services professionals, as well as graduate-level students in these fields. Other individuals may also benefit from this course such as educators and physicians. Continuing Education (CE) for licensure is available upon successful completion of course content.
As a learner, you have the ability to select any or all of the modules and topics that interest you. You can complete the course in a linear or non-linear structure according to your preferred viewing order. This course is taught by experts in the field of opioid prevention, intervention, treatment, and policy. Through lectures, panels and interviews, knowledge checks and quizzes, and additional readings and activities, you can explore topics that are most relevant to your work or practice.
The course was developed by three University of Michigan programs, including the Institute for Healthcare Policy and Innovation (IHPI), Michigan-Opioid Prescribing Engagement Network (Michigan OPEN) and the CDC-funded University of Michigan Injury Prevention Center.
The course consists of 6 “lessons” or modules of varying length, for a total commitment of about 15 hours. This translates to 15 CME and Michigan Social work continuing education credits, and 13 Michigan Pharmacy continuing education credits.
The University of Michigan Medical School designates this enduring material for a maximum of 15 AMA PRA Category 1 Credit(s)™. The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This course is approved by the Michigan Board of Pharmacy-Approval #539190044. This approval statement is for University of Michigan Institute for Healthcare Policy & Innovation. The Michigan Board of Pharmacy designates this enduring material for a maximum of 13 Continuing Education (CE) Hours. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity.
This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology™ (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.
If you would like to earn CME/MOCA credit for participating in this course, please review the information here prior to beginning the activity.
This course is approved by the Michigan Social Work Continuing Education Collaborative-Approval #101619-02 for 15 CE hours. The Collaborative is the approving body for the Michigan Board of Social Work.
At a glance
What you'll learnSkip What you'll learn
Explain the factors that contributed to the current opioid crisis.
Understand the pathophysiology of pain and its treatment, including what opioids are and how they work.
Understand how to reduce unintended use and misuse of opioids using various strategies, including prescribing guidelines, surveillance, safe disposal of unused opioids, and intervention messaging.
Identify what strategies and tools you can employ to impact the safe use of opioids across clinical care settings and with a variety of populations.
Describe best practices for assessing and treating opioid use disorder (OUD) and explain the evidence that informs these best practices.
Understand different aspects of public policy that can impact the opioid epidemic.